Bharat Biotech’s Covaxin Approved for Emergency Vaccination to 8-12 Age Group | NewsMo

Covaxin safe, well-tolerated in 2-18 years age-group: Bharat BiotechПодробнее

Bharat Biotech seeks emergency use approval for Covid-19 vaccine Covaxin|Oneindia NewsПодробнее

Covid-19 Vaccine: Bharat Biotech's Covaxin Approval Requested In US For Children Below 18Подробнее

Bharat Biotech Vaccine Approved For Trial On Children Above 12 Years, Covishield Above Age 18Подробнее

PM Modi Calls Out Opposition's Hypocrisy, Covaxin Approved For Kids In 2-18 Age & MoreПодробнее

Covaxin Approved For Trial On Children Above 12 Years, Covishield Above Age 18| Covid Vaccine NewsПодробнее

What Parents' Say Over Covaxin Gets Approval For Kids Aged 2-18 Years | Reporter DiaryПодробнее

Covaxin approved for restricted emergency use in children aged 6-12 years | Corbevax | Oneindia NewsПодробнее

DCGI allows Bharat Biotech to vaccinate children above 12 during clinical trial modeПодробнее

Covid Vaccine: Covaxin Approved For Kids Aged 2-18 Years | Breaking NewsПодробнее

Bharat Biotech’s COVID-19 vaccine for kids gets DCGI nod for emergency useПодробнее

Covid Vaccine For Kids: Covaxin Approved For Children In 2-18 Age Group | Covid 360Подробнее

Covaxin Gets Emergency Use Approval For Kids Aged 2-18 Years | Breaking NewsПодробнее

Bharat Biotech's Covaxin May Get Approval Any Time Soon For Emergency Use In India | Breaking NewsПодробнее

WHO Approves Bharat Biotech's Covaxin For Emergency UseПодробнее

Crucial WHO Meeting On Bharat Biotech's Covaxin Approval Concludes | Breaking NewsПодробнее

Relief For Parents As Covaxin Gets Emergency Use Approval For Kids Aged 2-18 Years | 6 PM PrimeПодробнее

Covaxin Approved For Kids In 2-18 Age Groups, Dr Rahul Pandit Speaks To India TodayПодробнее

Bharat Biotech Allowed To Conduct Vaccine Trials On Children Above 12Подробнее

Bharat Biotech's Covaxin Gets Approval For Emergency Use In India | India Today Milan Sharma ReportsПодробнее